Patents by Inventor Ly Pham

Ly Pham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organic Compounds
    Publication number: 20110065726
    Abstract: The present invention is directed to a compound of the formula: or pharmaceutically acceptable salts thereof and use of such compounds for treating proliferative diseases such as cancer, in mammals.
    Type: Application
    Filed: July 31, 2007
    Publication date: March 17, 2011
    Inventors: Zhuoliang CHEN, Sushil Kumar Sharma, Christopher Straub, Mark G. Charest, Feng He, Run-Ming David Wang, Leigh Zawel, Christine Hiu-Tung Chen, Miao Dai, Huangshu Lei, Ly Pham, Fan Yang
  • Aminofurazan compounds useful as protein kinase inhibitors
    Patent number: 7157476
    Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Grant
    Filed: August 20, 2004
    Date of Patent: January 2, 2007
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Jon H. Come, Jeremy Green, Craig Marhefka, Scott L. Harbeson, Ly Pham
  • Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
    Patent number: 6951848
    Abstract: Disclosed are novel compounds having the formula or a physiologically acceptable salt, amide, ester or prodrug thereof. The compounds can be used to modulate (antagonize, agonize) chemokine receptor function. Also disclosed is a method for treating a patient having an inflammatory disease and/or viral infection comprising administering an effective amount of a compound of Formula I. In particular embodiments, the invention is a method for treating a patient infected with HIV.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: October 4, 2005
    Assignee: Millennium Pharmaceuticals, Inc.,
    Inventors: Geraldine C. B. Harriman, Kenneth G. Carson, Daniel L. Flynn, Michael E. Solomon, Yuntao Song, Bharat K. Trivedi, Bruce D. Roth, Christine N. Kolz, Ly Pham, Kuai-lin Sun
  • Aminofurazan compounds useful as protein kinase inhibitors
    Publication number: 20050148640
    Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Application
    Filed: August 20, 2004
    Publication date: July 7, 2005
    Inventors: Jon Come, Jeremy Green, Craig Marhefka, Scott Harbeson, Ly Pham
  • Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
    Publication number: 20050075348
    Abstract: Disclosed are novel compounds having the formula or a physiologically acceptable salt, amide, ester or prodrug thereof. The compounds can be used to modulate (antagonize, agonize) chemokine receptor function. Also disclosed is a method for treating a patient having an inflammatory disease and/or viral infection comprising administering an effective amount of a compound of Formula I. In particular embodiments, the invention is a method for treating a patient infected with HIV.
    Type: Application
    Filed: November 8, 2004
    Publication date: April 7, 2005
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Geraldine Harriman, Kenneth Carson, Daniel Flynn, Michael Solomon, Yuntao Song, Bharat Trivedi, Bruce Roth, Christine Kolz, Ly Pham, Kuai-lin Sun
  • Phenylene alkyne matrix metalloproteinase inhibitors
    Patent number: 6849648
    Abstract: A compound of Formula I or a pharmaceutically acceptable salt thereof, or a tautomer thereof, wherein G1, G2, and B are as defined in the application, are selective inhibitors of MMP-13. The compounds are useful for treating diseases mediated by MMP-13, including cancer and arthritis.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: February 1, 2005
    Assignee: Warner-Lambert Company
    Inventors: Amy Mae Bunker, William Glen Harter, James Lester Hicks, Patrick Michael O'Brien, Ly Pham, Joseph Armand Picard, William Howard Roark
  • Alkyne matrix metalloproteinase inhibitors
    Publication number: 20030144274
    Abstract: A compound of Formula I 1
    Type: Application
    Filed: October 4, 2002
    Publication date: July 31, 2003
    Inventors: Amy Mae Bunker, William Glen Harter, James Lester Hicks, Patrick Michael O'Brien, Ly Pham, Joseph Armand Picard, William Howard Roark
  • Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
    Publication number: 20030064991
    Abstract: Disclosed are novel compounds having the formula 1
    Type: Application
    Filed: March 12, 2002
    Publication date: April 3, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Geraldine C.B. Harriman, Kenneth G. Carson, Daniel L. Flynn, Michael E. Solomon, Yuntao Song, Bharat K. Trivedi, Bruce D. Roth, Christine N. Kolz, Ly Pham, Kuai-lin Sun
  • Quinazolines as MMP-13 inhibitors
    Publication number: 20020193377
    Abstract: A compound selected from those of formula (I): 1
    Type: Application
    Filed: February 13, 2002
    Publication date: December 19, 2002
    Inventors: Charles Andrianjara, Nicole Chantel Barvian, Bernard Gaudilliere, Henri Jacobelli, Daniel Fred Ortwine, William Chester Patt, Ly Pham, Catherine Rose Kostlan, Michael William Wilson